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,WLVQRZQHDUO\\HDUVVLQFH3LMOV¶ILUVWGHVFULSWLRQ of the experimental basis for fractional 
flow reserve (FFR).  In that paper, the purpose of FFR ZDVVWDWHGDVµDVVHVVLQJWKHIXQFWLRQDO
VWHQRVLVVLJQLILFDQFHVHYHULW\EHIRUHDQGDIWHU37&$¶1.  Since then, and particularly in the last 
fifteen years, a wealth of evidence has accrued demonstrating that FFR guidance improves 
outcomes in patients being treated for coronary artery disease when compared with 
conventional angiographic guidance alone.  Adoption into the major guideline documents has 
since followed 2-4.  Yet FFR measurement is performed in only a small minority of patients.  
Why is this?   
 
First, FFR requires time to set up, pass the wire and infuse adenosine, all of which increase 
the procedure time.  Second, short-term cost is increased, even though FFR is cost-effective 
in the longer term.  Third, an experienced interventionist may feel that he /she knows which 
lesion(s) to treat and which not.  When faced with lesions of intermediate severity, diffuse 
disease and long segments, such subjective judgment is inaccurate.  Fourth, if non-invasive 
testing for ischemia has already provided a clear indication of the location of ischemia, FFR 
may not be necessary.  Fifth, the implications of a positive FFR result are that PTCA should 
be performed, and for this to happen there has to be planning for that procedure, with 
appropriate anti-platelet agents, counselling, and yet more time scheduled; time which, of 
course, may not, in the end, be used.  Sixth, the weight of evidence supporting FFR is in the 
context of chronic stable coronary disease, whereas the workload of the interventionist is 
increasingly made up of acute or unstable disease. 
 
So FFR XVHUHPDLQVµWUDSSHG¶ZLWKin the world of (largely elective) PTCA guidance, as 
originally outlined by Pijls, with less impact in the much larger group of patients undergoing 
general diagnostic angiography, investigation and treatment of acute coronary syndromes, or 
workup for coronary artery bypass surgery. 
 
There are attempts to liberate FFR from some of its limitations, such as abandoning 
adenosine by using iFR measurement5, adopting more non-invasive CT imaging allied to 
FFR estimation6, or (attempting to) introduce FFR at the time of diagnostic invasive 
angiography (NCT02892903).  All these represent valuable additions and potential 
improvements in the interventionists¶ armamentarium; but to address fully the day-to-day 
lack of physiology in the catheter laboratory, an alternative solution is needed. 
 
The prospect of a computed (in silico or µYLUWXDO¶) FFR calculated from angiographic images 
is, therefore, attractive.  The goal is to construct a three-dimensional (3D) model of the 
arterial anatomy in the computer, and simulate blood flow and pressure dynamics through the 
relevant segments, using well known physical laws, such as those embodied in computational 
fluid dynamics (CFD) 7.  The attraction is clear. Without the need to pass a guidewire, or 
infuse a drug, the cardiologist is presented with an FFR µURDGPDS¶alongside the angiogram, 
providing all the benefits of physiological guidance without the limitations that restrict use of 
the invasive technique. 
 
Multiple systems have been described, all with a broadly similar approach: (i) 3D arterial 
anatomy is reconstructed from angiographic projections >25° apart, using image analysis 
software; (ii) coronary blood flow (Q) and pressure (P) changes are simulated through the 
model applying fluid dynamic laws and physiological assumptions; (iii) the distal to proximal 
pressure ratios (Pd/Pa = FFR) are calculated; and (iv) the results are presented graphically to 
the user.  In 2013 Morris et al described the VIRTUheart system which computed FFR from 
rotational angiography using a relatively complex transient (time-varying pulsatile flow) 3D 
CFD analysis coupled to a zero-dimensional modified Windkessel 8.  This proof-of-concept 
study provided promising early results but lacked general applicability and was slow to 
compute (>24 hrs).  More recent development means VIRTUheart works using standard 
angiography and has been accelerated to ~3 mins computation time 9.  In 2014 Papafaklis et 
al used 3D QCA models to compute a novel index called µvirtual functional assessment 
index¶ (vFAI) 10.  They used paired steady-state CFD analysis (much faster than transient 
analysis) to plot the case-specific pressure-flow relationship and derive the Poisuille and 
Bernoulli constants.  vFAI was computed (~7 min), from the Pd to Pa ratio in the range 0-4 
ml/s, normalised by the ratio over this range for a normal artery.  Although superior to QCA 
vFAI was entirely a function of the geometry of the stenosis.  In the same year, Tu and 
colleagues introduced their model which also utilised 3D QCA models and CFD analysis but 
used the TIMI frame counting during hyperaemia to derive a measure of maximal coronary 
flow thus introducing a physiological parameter with which to tune the models 11.  In 2016, 
the same group published their Diagnostic Accuracy of Fast Computational Approaches to 
Derive Fractional Flow Reserve From Diagnostic Coronary Angiography (FAVOR) pilot 
study 12.  They demonstrated that good results could be generated from thrombolysis in 
myocardial infarction (TIMI) frame counting during resting conditions, even when 
hyperaemia was not induced.  In the same year Trobs et al published their model of computed 
FFR 13.  They tuned their simulations using µpublished estimates of coronary microvascular 
UHVLVWDQFH¶DQGK\SHUemic flow was simulated based upon the assumption of a normal 
physiological response to adenosine.  Results were generated in 40 s. 
 
And so we come to the paper by Pellicano et al in this Journal,14 in which the authors present 
their FFRangio tool, which reconstructs coronary anatomy in 3D virtual space and computes 
the pressure gradients across diseased segments.  They applied it in a prospective, 
randomised, multicentre trial in 184 patients with stable coronary disease, with 203 arteries 
studied, a modest size of study, but the largest of its kind so far.  FFRangio was computed with 
negligible bias and predicted physiological lesion significance ))5, with a measured 
FFR as the reference standard, with 88% sensitivity, 95% specificity and 94% overall 
diagnostic accuracy.  The 95% Bland-Altman limits of agreement (±1.96 SD) were -0.10 to 
+0.10.  It is worth discussing what these measures of accuracy mean in the world of FFR and 
in the day-to-day management of patients.   
 
For computed FFR, accuracy can be defined in several ways.  Diagnosing physiological 
lesion significance, LHSUHGLFWLQJDELQDU\RXWFRPH))5LVRIPRVWLPSRUWDQFHDQG
relevance to an interventionist.  Most virtual FFR models achieve >85% accuracy in this 
regard.  This is, of course, dependent upon the study-specific distribution of FFR cases, i.e. 
KRZFORVHO\WKHFDVHVDUHFOXVWHUHGDURXQGWKHWKUHVKROG3HOOLFDQRHWDODFKLHYHGDn 
overall diagnostic accuracy of 94% with 67% of cases falling between 0.70 and 0.90, which 
is impressive. 
 
Accuracy can also be judged according to how close an individual virtual FFR result is to the 
corresponding, directly measured, invasive FFR.  The best way to assess this is with a Bland-
Altman plot, in which the difference between two measurements is plotted against the mean 
value.  The limits of agreement (±1.96 SD) comprise 95% of the differences; and so the 
narrower the limits of agreement are, the better is the agreement between the two measures.  
Amongst the published models of virtual FFR, the limits of agreement are similar, and are of 
the order of ±0.10, as found in the study of Pellicano, but can be as wide as ±0.15.  In the 
context of FFR (0.00 to 1.00), ±0.10 is a relatively wide range, and somewhat undermines the 
value of an individual result. 
 
Given the methods used, Pellicano et al achieve an impressive inter-operator variability 
(intraclass correlation coefficient = 0.96) which implies a robust and repeatable 
reconstruction algorithm.  This is a real achievement given the challenges of segmenting and 
reconstructing the anatomical model from invasive coronary angiography.  Moreover, the 
image reconstruction software waVVDLGWREHDXWRPDWLFZLWKµPLQLPDOPDQXDOHIIRUWWRJXLGH
WKHSURFHVVLQJ¶DQGFDQEHSHUIRUPHGLQOHVVWKDQVHFRQGVOverall, the software platform 
and computational method appear to be simpler than in previous models, and are aimed more 
at the level of healthcare professionals than the research laboratory, and the authors 
emphasise its applicability within the clinic.  The segmentation method produces an 
axisymmetric (circular cross section) virtual artery which is used for FFRangio computation.  
Therefore, unlike intravascular imaging, it is unable to replicate eccentric plaque, which 
instead is radius-averaged over the selected projections.  Again, this is similar to other models 
and appears to be an acceptable approximation.  Recently published data demonstrate that 
accurately representing the arterial geometry is less important than accurately representing 
the outlet boundary condition (see below) 9.  A further strength was that the computation of 
FFRangio did not require any deviation from a standard, routine angiogram, making it 
potentially widely applicable.  Similar to other virtual FFR software platforms, the end result, 
a graphical 3D physiological roadmap, is attractive and nicely facilitates lesion assessment.  
In common with the work from other groups, lesions were simple, discrete and µtype A¶, 
whilst diffuse disease, ostial lesions and in-stent restenosis were excluded.  It will be 
interesting to see if the same level of accuracy is maintained when more complex and diffuse 
disease patterns are included, and if the same level of inter-observer variability is maintained 
when non-expert users outside of the research team run the analyses. 
 
Fluid dynamics purists may be critical of the method by which FFRangio was computed 
because the authors considered only PoiseuiOOH¶VODZ Trans-lesional fluid mechanics are 
complex and the Bernoulli pressure drop, due to convective acceleration through an arterial 
narrowing, is actually more dominant than the Poiseuille drop, due to viscous friction across a 
stenosis 15.  But even these laws of fluid dynamics are superseded by CFD which invokes the 
Navier-Stokes equations (the governing equations of fluid flow), which better characterise 
trans-lesional pressure and flow changes, including incomplete pressure recovery distal to the 
lesions.  The downside of 3D CFD is that, typically, it is complex, computationally 
expensive, and time-consuming; but recent advances have demonstrated that even 
complicated CFD methods can be accelerated and simplified HQRXJKIRUµRQ-WDEOH¶XVH9. 
 
A challenge in the area of modelling FFR lies in understanding the dominant, accuracy-
defining factors; those which need to be accurately represented, and those which can be 
averaged or assumed.  Sophisticated models may be accurate, but complexity can render 
them impractical outside the research laboratory.  Simpler models may be quicker and easier 
to use, but may not provide sufficient accuracy in all patients.  A key question is therefore: 
what is the simplest model that provides sufficient accuracy for clinical use?  Put another 
way, what is the optimal trade-off between accuracy and ease-of-use?  If sufficient accuracy 
can be provided by simpler models (where the user interface is simplified but underlying 
scientific methods retain sophistication) and /or methods (where the scientific method itself is 
simplified) then this is highly advantageous.  The latter appears to have been achieved by 
Pellicano and co-workers. 
 When computing FFR, aside from the accuracy of the segmented anatomical model, the 
major accuracy-defining factor is how the model LVµWXQHG¶WRrepresent the resistance of the 
distal myocardial microvessels 9.  This parameter determines coronary blood flow and is 
heterogeneous in healthy and diseased states.  For this reason, a model which performs fluid 
dynamics from imaging alone cannot actually compute FFR, a physiological index; and is, in 
effect, nothing more than DµIDQF\4&$¶0RGHOVWKHUHIRUHapply a prediction of 
microvascular resistance (or, conversely, hyperaemic blood flow) using assumptions.  
Maximum coronary flow is related to the accumulated sum of the distal luminal volume.  
Although not explicitly laid out in the paper Pellicano et al applied recognised allometric 
scaling (non-linear proportionality between diverse variables) laws to estimate normal blood 
supply demand from the volume of the reconstructed arterial tree.  Applying the correct 
resistance or flow is important.  If the applied resistance is lower (or higher) than the true 
microvascular resistance, then flow will be too high (or low) and the virtual FFR will be 
falsely decreased (or increased) thus over- (or under-) estimating lesion significance with the 
obvious potential consequence of stenting (or not) inappropriately.  If a method can be 
developed which can accurately predict or approximate to coronary microvascular resistance 
(or alternatively hyperaemic blood flow) on an individual case-by-case basis, then virtual 
FFR results will more closely match invasive FFR results, and limits of agreement will 
improve.  This is a major challenge for researchers in this field 16.   
 
Beyond such methodological challenges, the interventional and regulatory communities will 
need to decide what constitutes µVXIILFLHQWDFFXUDF\¶ for routine clinical use ± a question 
which was asked in the same journal last year 17.  Because neither index is perfect, and since 
virtual FFR will almost certainly never match invasive FFR perfectly in all cases, perhaps 
this is better assessed in randomised outcome trials than in observational numerical 
comparisons, notwithstanding the limitations of serial non-inferiority trials.  HeartFlow, Inc 
(Redwood City, CA), the company behind CTFFR, has demonstrated that in silico techniques 
can be successfully translated routine clinical practice and gain regulatory approval 18; an 
important step forward in the introduction of computer modelling to assist decision making in 
heart disease. 
 
:KHWKHUFRPSXWHGµYLUWXDO¶SK\VLRORJ\represents part of the future for invasive coronary 
angiography remains to be seen.  It is likely that several systems will be developed along 
similar lines, and there remain methodological and regulatory challenges which need to be 
resolved.  But the critical leap, of which this is the first step, will be to open up coronary 
physiology to the majority of patients undergoing a diagnostic invasive coronary angiogram, 
either offline, or preferably in the catheter laboratory, using images recorded in-house or 
from elsewhere, in stable, unstable, PTCA or potential CABG patients.  In silico techniques 
have the potential to achieve this.  The introduction of a practical computer model which 
brings physiology into an otherwise anatomical test is to be welcomed.  In the longer term, it 
will be interesting to see if in silico techniques can be used to develop an index which is not 
simply equivalent (or non-inferior) to FFR, but that can improve upon it. 
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